{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:50:17Z","timestamp":1789861817955,"version":"4.0.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3321,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.1995.tb02488.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T15:41:29Z","timestamp":1279726889000},"page":"32-36","source":"Crossref","is-referenced-by-count":33,"title":["p53 protein expression in cutaneous T-cell lymphomas"],"prefix":"10.1093","volume":"133","author":[{"given":"A. F.","family":"LAURITZEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"VEJLSGAARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"HOU-JENSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"RALFKIAER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,7,29]]},"reference":[{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0092-8674(79)90293-9","article-title":"Characterization of a 53 K-Dalton cellular SV-40 tumor antigen present in SV-40 transformed cells and uninfected embryonal carcinoma cells","volume":"17","author":"Linzer","year":"1979","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/278261a0","article-title":"T-antigen is bound to host protein in SV40 transformed cells","volume":"278","author":"Lane","year":"1979","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.4.1.1","article-title":"P53: oncogene or antioncogene?","volume":"4","author":"Lane","year":"1990","journal-title":"Genes Dev"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB4|cit4","first-page":"67","article-title":"The p53 cellular tumour antigen: gene structure, expression and protein properties","volume":"823","author":"Oren","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/352345a0","article-title":"Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6","volume":"352","author":"Yonish-Rouach","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V82.4.1092.1092","article-title":"Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents","volume":"82","author":"Lotem","year":"1993","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB7|cit7","first-page":"1699","article-title":"Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies","volume":"6","author":"Bartek","year":"1991","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/329219a0","article-title":"Functional inactivation of genes by dominant negative mutations","volume":"329","author":"Herskowitz","year":"1987","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"P53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukaemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1128\/MCB.3.12.2143","article-title":"Two distinct mechanisms regulate the levels of a cellular tumour antigen, p53","volume":"3","author":"Reich","year":"1983","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.2910410204","article-title":"P53 expression in breast cancer","volume":"41","author":"Cattoretti","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood.V80.12.3205.3205","article-title":"Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia\/lymphoma shows frequent p53 mutations","volume":"80","author":"Cesarmann","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V79.8.1982.1982","article-title":"Constitutive expression of p53 protein in enriched normal human marrow blast cell population","volume":"79","author":"Rivas","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB15|cit15","first-page":"33","article-title":"P53 and oncogenes expression in psoriasis","volume":"146","author":"Tadini","year":"1989","journal-title":"Acta Derm Venereal Suppl (Stockh)"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB16|cit16","first-page":"1343","article-title":"Immunohistochemical analysis of p53 expression in malignant lymphoma","volume":"141","author":"Said","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1992.tb08213.x","article-title":"Mutations of the p53 tumour suppressor gene in haematologic neoplasms","volume":"81","author":"Mori","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1699-0463.1993.tb00166.x","article-title":"P53 protein expression in Hodgkin's disease","volume":"101","author":"Lauritzen","year":"1993","journal-title":"APMIS"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB19|cit19","first-page":"845","article-title":"High levels of p53 protein expression do not correlate with mutations in anaplastic large cell lymphoma","volume":"143","author":"Cesarman","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB20|cit20","first-page":"573","article-title":"Postthymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations","volume":"144","author":"Matsushima","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V79.10.2701.bloodjournal79102701","article-title":"Mutations of p53 gene and their relation to disease progression in B-cell lymphoma","volume":"79","author":"Ichikawa","year":"1992","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/path.1711660305","article-title":"P53 protein expression in lymphomas and reactive lymphoid tissue","volume":"166","author":"Villuendas","year":"1992","journal-title":"J Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb00067.x","article-title":"Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphomas","volume":"22","author":"Pezzella","year":"1993","journal-title":"Histopathology"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.1993.tb00164.x","article-title":"P53 protein expression in benign and malignant skin tumours","volume":"128","author":"Ro","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ajcp\/84.5.610","article-title":"Phenotypic characterization of lymphocyte subsets in mycosis fungoides","volume":"84","author":"Ralfkiaer","year":"1985","journal-title":"Am J Clln Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"i","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/39.6.1709656","article-title":"Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for irnmuno-histochemical staining based on microwave oven heating of tissue sections","volume":"29","author":"Shi","year":"1991","journal-title":"J Histochem Cytochem"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/320084a0","article-title":"Localisation of gene for human p53 tumour antigen to band 17pl3","volume":"320","author":"Isobe","year":"1986","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0092-8674(89)90045-7","article-title":"The p53 proto-oncogene can act as a suppressor of transformation","volume":"57","author":"Finlay","year":"1989","journal-title":"Cell"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/JVI.63.2.739-746.1989","article-title":"Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation","volume":"63","author":"Hinds","year":"1989","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/MCB.8.2.531","article-title":"Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life","volume":"8","author":"Finlay","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-1759(92)90122-A","article-title":"An immunochemical analysis of the human nuclear phosphoprotein p53","volume":"151","author":"Vojtesek","year":"1992","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.35.3.592-602.1980","article-title":"Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000 Dalton subunit","volume":"35","author":"Luka","year":"1980","journal-title":"J Virol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/path.1711680311","article-title":"High incidence of EBV genome in CD-30 positive non-Hodgkin's lymphomas","volume":"168","author":"Kanavaros","year":"1992","journal-title":"J Pathol"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","article-title":"The p53-mdm2 autoregulatory feedback loop","volume":"7","author":"Wu","year":"1993","journal-title":"Genes Dev"},{"key":"10.1111\/j.1365-2133.1995.tb02488.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711720103","article-title":"P53 in tumour pathology: can we trust immunohistochemistry?-Revisitedl","volume":"172","author":"Hall","year":"1994","journal-title":"J Pathol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1995.tb02488.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.1995.tb02488.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:58:26Z","timestamp":1676383106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/133\/1\/32\/6682064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,29]]},"references-count":36,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb02488.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,29]]}}}